All Careers Advice

  • AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with 212Pb-ADVC001, a Targeted Alpha Therapy in development for the treatment of PSMA-positive metastatic CastrationResistant Prostate Canc...
  • Berlin's Rejuvenation Summit, May '24: CEOs, startups, investors meet for anti-aging biotech advancements. Network, invest, reverse aging diseases.
  • Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces the open-label safety lead-in of its integrated AIPAC-003 Phase II/III trial evaluating for the v...
  • Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, has signed an agreement with P3 Research Ltd Network. The agreement further expands the Company’s clinical trial capabilities across a broader range of therapeutic areas in New Zealand (NZ).
  • In this article, we highlight some of the top associations dedicated to Regulatory affairs for you to explore. These associations have a proven track record of providing exceptional opportunities for Regulatory affairs professionals, and of working collaboratively with members to advocate for exc...
  • By leveraging the latest advances in machine learning and natural language processing, AI tools can help you reduce bias in your hiring, helping you to ultimately build a more diverse, talented, and productive workforce. In this article, we introduce 10 of the top AI-powered tools and platforms f...
  • Chimeric Therapeutics (ASX:CHM, "Chimeric" or the "Company"), an Australian leader in cell therapy, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of CHM 2101, Chimeric's first in class CDH17 CAR T cell therapy for gastr...
  • LEO Pharma's DELTA 3 trial on delgocitinib cream for chronic hand eczema (CHE) shows positive long-term safety & efficacy. Continuity in symptom relief and treatment success observed for up to 36 weeks, promising for CHE patients.
  • A Biotechnologist is a scientist who uses living cells, organisms, and bioprocesses to create new products and technologies that benefit society. Some of their responsibilities include researching and developing new drugs, creating genetically modified crops, studying the mechanisms and functions...
  • Clarity Pharmaceuticals and PSI CRO AG (“PSI”) have entered into an agreement and have commenced work towards Clarity’s Phase III diagnostic trial of SAR-bisPSMA in prostate cancer participants, CLARIFY (NCT06056830)1.
  • 83% of employees feel that recognition affects their motivation to succeed at work, and 77.9% feel they would be more productive if they were recognised more frequently. As well as improving overall productivity, employee recognition plays a crucial role in fostering a positive work culture, boos...
  • • Focus on executing the strategic plan and delivering shareholder value • First MDG2011 pre-clinical data support potential in solid tumor therapy • Expansion of patent portfolio and license agreement for technologies in our End-to-End Platform • Guidance confirmed; cash runway maintained th...
  • In this article, we’ve outlined 8 strategies to help you succeed in your next panel interview. By incorporating these into your interview preparation, you’ll be able to showcase your expertise, build a personal connection with your interviewers, and make a memorable impression on the entire panel.
  • As a life science recruiter or hiring manager, posting your jobs at the right time is crucial for several reasons. First and foremost, it increases the visibility of your job postings. By strategically timing your posts, you can ensure that they appear at the top of search results when candidates...
  • Immutep Limited announces excellent new clinical data from the TACTI-002 / KEYNOTE-798 Phase II trial evaluating eftilagimod alpha (“efti”), a soluble LAG-3 protein and first-in-class MHC Class II agonist, in combination with MSD’s (Merck & Co., Inc., Rahway, NJ., USA) anti-PD-1 therapy KEYTRUDA®...
  • In this article, we explore 9 reasons why you should consider embarking on the fulfilling journey of mentorship, highlighting what you could gain from the process as well as what you could contribute to it.
  • Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced the suc...
  • The realm of modern medicine stands on the shoulders of groundbreaking scientific discoveries and milestones that have shaped our understanding of diseases, treatments, and patient care. Amongst these milestones, one particular event emerged as a turning point in the history of medical research –...
  • For life science recruiters, finding candidates with not only the right technical expertise but also strong soft skills is crucial for success. In this article, we’ve outlined 8 tools that harness the power of AI to identify top talent who possess the soft skills needed to excel in the life scien...
  • Newly added manufacturing capabilities at eXmoor’s Cell and Gene Therapy Centre in Bristol, UK will help developers take advanced therapies from concept to clinic